Publications by authors named "L Vahdat"

Claim this Profile
T
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02.
S A Hurvitz, S Loi, J O'Shaughnessy, A F C Okines, S M Tolaney, L Vahdat

Ann Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of elemental imaging and spatial transcriptomic profiling for proof-of-concept metals-based pathway analysis of colon tumor microenvironment.
Aruesha Srivastava, Neha Shaik, Yunrui Lu, Matthew Chan, Alos Diallo, Linda Vahdat

Metallomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Customized Nanofibers with Lung-Targeting and -Retention Properties for Treating Isolated Triple-Negative Breast Cancer Pulmonary Metastases.
Vanessa Bellat, Adam Glaser, Henry Gong, Aman Gill, Young Jae Lee, Linda Vahdat

ACS Nano· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
Erika P Hamilton, Rinath M Jeselsohn, Linda T Vahdat, Sara A Hurvitz

Target Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative co-registration of elemental imaging and histopathology for enhanced spatial multimodal analysis of tissue sections through TRACE.
Yunrui Lu, Serin Han, Aruesha Srivastava, Neha Shaik, Matthew Chan, Linda Vahdat

Bioinform Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis